The agreements with US companies Novavax and Pfizer will deliver an extra 50 million doses, if they prove safe and effective.
While scientists working on the front runner Oxford Vaccine, say it might be ready by the end of this year.
Kulasegaram Sanchayan reports in Tamil with a feature written by Amelia Dunn.